Deep Tech Startups
5,885 companies tagged Deep Tech, with their investors and founders.
Ternary Energy develops electrochemistry-based solutions to provide secure, affordable, emissions-free energy to industrial and urban customers. The company focuses on commercializing its liquid electricity technology for integration within existing operational and regulatory systems.
3 investors
Terra AI develops AI and decision-making software for mining and energy companies to accelerate subsurface exploration and resource extraction. The company focuses on de-risking post-discovery exploration for critical minerals, geothermal energy, and carbon storage projects.
3 investors
Terremoto Bio develops next-generation small-molecule therapies using medicinal chemistry, targeting previously "undruggable" disease areas. The company focuses on drug candidates designed for improved efficacy and patient outcomes.
3 investors
Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.
3 investors
Terrisei integrates data from space, air, ground, and underwater sources to build 3D digital profiles of physical assets and infrastructure, letting teams remotely explore sites and detect terrain changes, patterns, and anomalies with an AI engine. The platform serves asset and infrastructure operators for monitoring and inspection.
3 investors
Theradaptive develops protein engineering technology that modifies recombinant proteins into material-binding variants for targeted therapeutic delivery, aiming to improve efficacy and reduce off-target effects. Its applications span more than a dozen clinical indications including spinal fusion, orthopedics, soft tissue repair, and targeted chemotherapeutics.
3 investors
SyntheX is a drug discovery company that engineers cells using its ToRFLEx platform to run target-centric, cell-based functional selection for challenging protein targets and novel mechanisms of action. It applies synthetic biology to identify drugs that modulate protein classes historically considered undruggable, such as those altering protein levels or interactions.
3 investors
3 investors
Time is Brain develops BraiN20®, a real-time brain monitoring device for stroke patients that provides bedside neurological data to guide treatment decisions during time-critical interventions. The portable, non-invasive system is designed for healthcare professionals managing acute stroke care across hospitals and clinical settings.
3 investors
TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas. The company operates an integrated innovation, design, manufacturing, and commercialization platform serving its own programs and co-development partnerships in the medtech industry.
3 investors
ToffeeX develops physics-driven generative design software for engineers to create optimized designs for thermal and fluid components such as heat sinks, cold plates, manifolds, and cooling systems. Its tools are used on engineering projects for organizations including Airbus, Ricoh, and CERN.
3 investors
Trace is a platform for creating and publishing augmented reality experiences across retail, events, training, and real estate. It provides tools for designing AR content on mobile and desktop, with support for persistent spatial anchoring and multi-device viewing.
3 investors
TrainLoop is a post-training research lab that trains specialized AI models for enterprise customers in pharma, biotech, logistics, and banking. The company develops custom foundation models and agents optimized for long-horizon tasks and mission-critical workflows in high-risk industries.
3 investors
Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.
3 investors
Triplebar builds an AI platform for Genomic Design Automation (GDA), using microfluidics to generate large-scale biological datasets with matched genotype and phenotype at lower cost and faster than liquid handling robotics. It applies machine learning to biological data to support biotechnology research and product engineering.
3 investors
TRL11 provides a video and visual intelligence platform for space operators, delivering real-time visibility across mission stages including capture, processing, transmission, and sharing. The integrated stack connects data from orbit to the operator.
3 investors
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications. The company works on novel gene network therapies for challenging diseases.
3 investors
TVARIT is a deep-tech company that develops a patented industrial AI platform (TiA) for foundries and metalworking manufacturers to improve overall equipment efficiency and reduce waste and energy use. It targets sustainable, zero-waste manufacturing in the metal production industry.
3 investors
U-MAP is a University of Nagoya spin-off developing new thermal-management materials to address heat problems in electronic devices such as smartphones, PCs, electric vehicles, data centers, and 5G equipment. Its material aims to solve challenges that conventional industrial materials could not.
3 investors
uFraction8 develops microfluidic filtration technology that uses precisely patterned chip geometries stacked into modules to process and separate liquids at high volume without damaging cell viability. The systems are aimed at scaling bioprocessing from lab to production, having been tested with HEK and CHO cell lines.
3 investors
Undermind provides AI-powered research discovery tools that help R&D teams find relevant scientific papers and research quickly. The platform serves biotech and pharmaceutical companies conducting drug discovery and development work.
3 investors
UNISERS develops contamination detection tools for semiconductor manufacturers, using a vacuum-based plasma coating technology combined with optical microscopy (SEPS and SERS techniques) to detect and characterize nanoparticle contaminants on silicon wafers. The company builds fully-automated fab tools that help manufacturers locate contamination sources faster to reduce wafer waste and improve yield.
3 investors
UniteLabs provides a lab automation platform that lets biotech and pharma teams define and run laboratory workflows as Python code, integrating 175+ devices through a single cloud API. Its "Lab As Code" approach offers version control, bidirectional device connectivity, and integration with LIMS/ELN tools such as Benchling for R&D labs.
3 investors
Thesis develops reusable, steerable microballoons for routine access to the stratosphere (40,000–130,000 feet), enabling persistent surveillance, communications relay, and atmospheric research for defense, intelligence, commercial, and scientific applications.
3 investors